or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 24 tumour microenvironment PhD Projects, Programmes & Scholarships
tumour microenvironment PhD Projects, Programmes & Scholarships
We have 24 tumour microenvironment PhD Projects, Programmes & Scholarships
Self-funded PhD- Understanding tumour-mediated suppression of cytotoxic T cell function by rebuilding it in vitro
Summary. Cytotoxic T cells have the capability of killing tumour target cells. However, this ability is commonly suppressed within the tumour microenvironment. Read more
Self-funded MSc R- Understanding tumour-mediated suppression of cytotoxic T cell function by rebuilding suppression in vitro
Summary. Cytotoxic T cells have the capability of killing tumour target cells. However, this ability is commonly suppressed within the tumour microenvironment. Read more
CRUK Black Leaders in Cancer Non-Clinical PhD Scholarship: The ageing tumour microenvironment in ER+ breast cancer - identifying age-associated regulators of cytotoxic T-cell infiltration and activity
This programme is aimed at students from Black heritage backgrounds pursuing a PhD in cancer-related fields. This scheme is open to people who self-identify as being from a Black heritage background, including a mixed background, for example. Read more
Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
Research Group:
Institute of Cancer Therapeutics
Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis. Read more
AI-driven signal and imaging analysis in cancer diagnosis
Cancer remains one of the leading causes of death worldwide. Increasing evidence indicates that how cancers develop and respond to treatments is linked to each patient’s unique tumour microenvironment. Read more
Signaling cross talks between cancer cells and infiltrating tumour monocytes and T cells
Immunotherapy has emerged as the fifth pillar of cancer therapy in addition to surgery, radiotherapy, chemotherapy and targeted therapy. Read more
Identification of regulators of cytotoxic T-cell infiltration and activity in ER+ breast cancer
Immunotherapy has revolutionised cancer treatment in recent years with impressive anti-tumour activity and clinical benefit observed in a range of cancers, including triple-negative breast cancer (TNBC) (1,2). Read more
Discovering immune biomarkers of pleural malignancy to improve patient care
This is a cutting-edge, translational PhD project that is supported by a team of world-leading cancer biologists, respiratory physicians and material scientists and aims to identify and characterise immune biomarkers of pleural malignancy to improve patient care. Read more
Integrating Electrical Fields with Smart Nanoparticles and Biomimetic Hydrogels for Targeted Glioblastoma Therapy
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumour in adults, with a high recurrence rate and limited treatment options. Read more
Recreating the Head and Neck Cancer Microenvironment
Project details. Head and Neck cancer (HNC) is a significant cause of mortality and morbidity worldwide, ranking as the 6th most common cause of cancer incidence and mortality in the world. Read more
Novel targeted chemotherapeutics for brain tumours
Research Group:
Institute of Cancer Therapeutics
Glioblastoma multiforme (GBM) is the most common and aggressive adult primary brain tumours. Standard treatment for GBM includes surgery followed by radiotherapy and temozolomide chemotherapy but the survival rates are very poor (only around 25% survive the first year and less than 5% have a five-year survival rate). Read more
Last chance to apply
PhD Studentship in Medicinal Chemistry, Development of USP18 Inhibitors
Research Group:
Edinburgh Cancer Research Centre
Immunotherapy has transformed cancer treatment by boosting the immune system to target and destroy tumour cells. However, resistance to immunotherapy and immunologically 'cold', immunosuppressed tumours remain significant challenges. Read more
Improving the therapeutic immunity of cancer vaccines with multi-adjuvant polymeric nanoparticles
Professor Sebastien Perrier (Department of Chemistry and Medical School, University of Warwick). Dr Shashi Prasad Rama (University Hospital Coventry and Warwickshire). Read more
Do nutrient availability and the extracellular matrix affect therapy response in cancer?
The tumour microenvironment (TME) plays a pivotal role in controlling cancer progression and response to therapy. A key component of the TME is the extracellular matrix (ECM), a complex network of secreted protein involved in controlling a variety of cell functions, including proliferation and migration. Read more
Postgraduate Research Opportunities at the Faculty of Medicine and Dentistry
To deliver our research strategy of ‘Better Health for All' and our aspiration to train the research leaders of the future, the Faculty of Medicine and Dentistry (top 10% faculties of medicine in the world, QS2022) has opened opportunities for self-funded PhD students in multiple areas of biomedical and translational research across six internationally recognised Research Institutes. Read more
- 1
- 2